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Abstract
Background: The purpose of this clinical study was to assess the prevalence of acidic oral mucosal lesions and
periodontal conditions in patients suffering from erosive esophageal reflux disease (ERD) compared with non
erosive esophageal reflux disease (NERD) patients, both treated with long term proton pump inhibitors (PPI).
Methods: Seventy-one patients with diagnosed GERD were studied: i.e. 29 ERD and 42 NERD patients. Thorough
visual examination of the oral mucosa and a periodontal evaluation was performed. The primary outcome was
defined as a statistically significant difference, between the two groups, in the presence of acidic lesions of the oral
mucosa and specific periodontal parameters.
Results: This study failed to demonstrate statistically significant differences between ERD and NERD patients with
respect to the prevalence of oral mucosal lesions. However, significantly more ERD patients suffered from severe
periodontitis (CAL ≥ 5 mm) as compared to NERD patients. Accordingly, it may be assumed that PPI-use had no
adverse effects on the prevalence of acidic oral mucosal lesions and on periodontal destruction.
Conclusions: Within the limitations of this study it may be concluded that ERD and NERD patients need separate
evaluation with respect to periodontal destruction. Moreover, long term PPI medication had no adverse clinical
impact on acidic oral mucosal lesions and periodontal destruction. Further studies are necessary to elucidate the
role of reflux in the periodontal destruction of ERD individuals.
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Background
One of the most important clinical conditions for retro-
grade movement of gastric acid into the oesophagus is
the gastroesophageal reflux disease (GERD) affecting ap-
proximately 10–20 % of the population in the western
world [1]. Clinically, typical esophageal symptoms of
GERD can occur such as heartburn and acid regurgita-
tion, while on the other hand atypical symptoms such as
a burning feeling on the tongue and oral mucosa can be
found [2].
However, GERD patients are not a homogenous group.
According to the endoscopic diagnosis, an erosive esopha-
gitis (ERD) and a non erosive reflux disease (NERD) may
be differentiated. These two main phenotypes of GERD
appear to have different pathophysiological and clinical
characteristics [3]. The standard therapeutic medical ther-
apy of both phenotypes of GERD includes the administra-
tion of acid-suppressive agents, proton pump inhibitors
(PPI) [4]. However, erosive esophagitis and NERD clearly
diverge when it comes to response to antireflux treatment.
NERD patients have a significantly lower response rate to
proton pump inhibitor (PPI) therapy, and consequently
they constitute the majority of the refractory heartburn
group [3].
Recent literature has pointed out that other extraeso-
phageal symptoms of GERD are acidic lesions of the oral
mucosa. It has been demonstrated histologically in rats
[5] that gastric acid reflux can cause acidic lesions of the
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palatal mucosa. These findings suggested that these
pathological changes may reflect the relationship be-
tween laryngopharyngeal reflux and airway obstruc-
tion also in humans. Moreover, GERD was reported
to be associated with microscopic alterations in the
palatal mucosa, such as epithelial atrophy and in-
creased fibroblast numbers [6]. In addition, objective
oral mucosal changes were found to be significantly
associated with GERD [7]. Also Järvinen et al. pointed
out the presence of burning mouth, aphthoid lesions
and hoarseness in patients with disorders of the upper di-
gestive tract. Erythema of the soft palate and uvula, glossitis,
epithelial atrophy, xerostomia could be common in GERD
patients [8]. However, it was objected that the mucosal
changes described are quite common and not pathogno-
monic and specific of GERD patients [9, 10]. Similarly, in a
clinical study on 117 patients with reflux disease, no muco-
sal changes could be observed to be linked with the reflux
disease [11].
Accordingly, it may be assumed that these controver-
sial findings are attributable to different proportions of
ERD and NERD patients in the respective studies.
Nevertheless, in most studies on oral findings, GERD
patients were not subdivided in the two subgroups.
Similarly, most recent literature has stated that GERD
was independently associated with an increased inci-
dence of chronic periodontitis; however, the two pheno-
types of GERD were not evaluated separately [12].
Therefore, the purpose of this study was to determine if
ERD patients show different oral soft tissue findings and
periodontal conditions as compared to NERD patients,
both with ongoing PPI therapy.
Material and methods
Ethic statement
All clinical investigations and procedures have been con-
ducted according to the principles expressed in the Dec-
laration of Helsinki. Patient informed consent was
written. The study was approved by the local ethic com-
mittee of the Klinikum rechts der Isar.
Patients
From March 2009 to March 2010, a total of 201 gastro-
esophageal outpatients of the Department of Internal
Medicine II (Head: Univ.-Prof. Dr. R. M. Schmid) of this
University who were at least 18 years of age were in-
formed by the internist on the purposes of this study. In-
clusion criteria were patients who had shown evidence for
GERD on functional testing (pH monitoring combined
with impedance measurement) and/or the confirmation of
an erosive form (esophagogastroduodenoscopy). More-
over, included patients had to have at least two molars,
two premolars and four anterior teeth free of prosthetic
crown restoration in each jaw. Patients were excluded
from the study if they had removable dentures, had under-
gone radiotherapy in the head and neck area, bisphospho-
nate therapy, or had a history of alcohol or illicit drug use.
In consequence, a total of 71 patients met criteria and
provided informed consent for oral evaluation (Fig. 1).
During evaluation, ethnicity, number of teeth and smok-
ing habits (yes/no) were recorded. To eliminate bias, the
only dentist (A. R.) who performed all the dental exams
was blinded. Hence, she did not know whether a particu-
lar patient had been diagnosed with ERD or NERD.
Medical history
All patients had to show a history of long term PPI ther-
apy (>1 year). In addition, details of the health status
were assessed.
Oral mucosa
Acidic mucosal lesions were examined in the palatal,
buccal, and tongue mucosa using the following scoring
system: score 0, no inflammation; 1, redness; and 2, ul-
ceration [13]. Accordingly, presence of erythema and/or
ulcer was included in the definition of acidic mucosal
lesions. Inspection was performed with use of a loup
(Carl Zeiss, Jena, Germany, magnification × 2.3).
Periodontal parameters
Oral hygiene was measured for each tooth according to
the criteria for the Plaque Index [14]. In this Index, a
score of 0 means no plaque and score 1 that a film of
plaque is adhering to the free gingival margin and adja-
cent area of the tooth. Moderate accumulation of soft
deposits within the gingival pocket, or the tooth and gin-
gival margin which can be seen with the naked eye, is
210 gastroesophageal outpatients
Met criteria: 71 patients
ERD-Group
29 patients
NERD-Group
42 patients
Statistical Analysis
Fig. 1 Flow chart of patients
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assigned to score 3. Abundance of soft matter within the
gingival pocket and/or on the tooth and gingival margin
is assigned to score 4. For assessment of bleeding sites
which indicate local inflammation, a modified bleeding
on probing index (BOP) was scored as percentage of
sites that showed bleeding 30 seconds after gentle prob-
ing of the bottom of the pockets [15]. The clinical at-
tachment loss (CAL) was measured with the WHO
probe (Morita, Kyoto/Japan) [16] from the cemento- en-
amel junction to the bottom of the pocket on four sites
(mesio-vestibular, disto-vestibular, mesio-oral and disto-
oral) [17]. Severity of periodontal condition was de-
scribed for all the individual sites as a whole and was
categorized on the basis of clinical attachment loss as se-
vere in case of CAL ≥ 5 mm [18].
Documentation
All parameters and findings were documented in stan-
dardized forms, which allowed comparison. Oral mucosa
was documented by digital photographs (Finepix AX
300, FUJIFILM Europe GmbH, D-Düsseldorf ).
Statistical analysis
Statistical analysis was performed using a commercial
computer program (NeoOffice 3.1.1, Planamesa Inc., 123
Main St. Sunnyvale, California, USA and StatXact-program,
version 5.0.3, Cytel Inc., Cambridge, Massachusetts, USA).
Statistical significance was tested by the Chi-square test and
Student’s t test. A p-value less than 0.05 was considered to
indicate statistical significance.
Results
Patients
The study encompassed a total of 71 patients, 41 women
and 30 men, with a mean age of 49.7 years (SD ± 15.1 years,
range: 22–83 years). In detail, the ERD group consisted of
29 patients and comprised 16 women and 13 men with a
mean age of 48 ± 16 years (range: 22–83 years). In the
NERD group, 25 women and 17 men were included with a
mean age of 50.9 ± 14.5 years (range: 25 – 74 years).
With respect to conservative dental restorations (fillings,
endodontic treatment) or fixed prosthetic dental recon-
structions, there was no significant difference between the
ERD and NERD patients. Study participants in both
groups consisted in all cases of Caucasian individuals.
With respect to the number of teeth and smoking habits,
there were no significant differences (Table 1). All smokers
in this study used to smoke cigarettes. No other forms of
tobacco such as spit tobacco, cigars and pipes were
consumed.
Medical history
With respect to medical care, all study patricipants had
provided name and address of their family doctors and
family dentists and had confirmed to see them regularely.
According to the inclusion criteria, all 71 patients (100 %)
were prescribed periodically PPI over the long term (>1 year,
mean: 1.3 years ± 4.5 months; range: 1.0–3.2 years) which
was ongoing at the time of evaluation. However, three of
them in the NERD group were classified as non-
responders. In addition, medical history of the 71 patients
revealed no impact on oral mucosa.
Oral mucosa
A total of eight patients in the ERD group and 11 NERD
patients showed moderate erythema of the oral mucosa
(score 1). In both groups, erythemas were localized
equally on the palatal and buccal mucosa and the mu-
cosa of the tongue. No patient demonstrated ulcer of the
mucosa. Statistical analysis failed to demonstrate signifi-
cant differences between scores and groups (Table 2).
Table 1 Initial data of the ERD and NERD group. No statistical
significance between the two groups detectable
Parameter ERD group (n = 29) NERD group (n=42) p Difference
significant?
Age
(mean ± SD)
48.0 ± 16.03 50.9 ± 14.5 0.43 No
Range (years) 22–83 25 – 74
Female
(n = 41)
16 25 0.22 No
Male
(n = 30)
13 17 0.22 No
Caucasian
ethnicity
100 % (n= 29) 100 % (n = 42) 0 No
Teeth
(mean ± SD)
20.6 ± 8.4 18.8 ± 7.6 0.35 No
Smoking 7 (24.1 %) 12 (28.6 %) 0.17 No
Table 2 Acidic oral mucosal lesions palatal (PM), buccal (BM),
and tongue mucosa (TM). No statistical significance between
scores and groups
Clinical
symptom
ERD group (n= 29) NERD group (n= 42) p Difference
significant?
PM score 0 25 (86.2 %) 36 (85.7 %) 0.95 No
PM score 1 4 (13.8 %) 6 (14.3 %) 0.95 No
PM score 2 0 0 1 No
BM score 0 27 (93.1 %) 38 (90.5 %) 0.69 No
BM score 1 2 (6.9 %) 4 (9.5 %) 0.69 No
BM score 2 0 0 1 No
TM score 0 27 (93.1 %) 40 (95.2 %) 0.70 No
TM score 1 2 (6.9 %) 2 (4.8 %) 0.70 No
TM Score 2 0 0 1 No
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Periodontal parameters
With regard to the oral plaque index, similar levels of
oral hygiene were found in both groups. ERD patients
showed a higher percentage of BOP as compared to
NERD patients. However, statistical analysis failed to
demonstrate significance on the 5 % level. Similarly,
mean CAL values showed no significant differences.
However, significantly more ERD patients suffered from
severe periodontitis (CAL ≥ 5 mm) as compared to
NERD patients (Table 3).
Discussion
Recent literature has pointed out that, with respect to
GERD patients, only controversial epidemiological data
on the prevalence of acidic oral mucosa lesions are avail-
able [9]. Moreover, most recent literature demonstrated
that GERD is independently associated with an increased
incidence of chronic periodontits. However, GERD and
periodontitis are frequent chronic diseases and PPI
medication generates costs for the public health care
system. Therefore, clinical studies are urgently necessary
to find out if there is an association between the main
two subgroups of GERD and acidic oral mucosal lesions
(erythema or ulcer) and periodontal conditions with re-
spect to PPI medication.
Several studies on oral findings in GERD patients pro-
vide only limited information if or how GERD was diag-
nosed (endoscopy solely [19], esophageal pH monitoring
in combination with impedance measurement [20]) or
treated before the study was carried out [19, 21–23],
which hampers reliable comparison with the present re-
sults. In this study, all patients had shown evidence for
GERD on functional testing (pH monitoring combined
with impedance measurement) and/or the histological
confirmation of an erosive GERD (esophagogastroduo-
denoscopy). Moreover, in this study, both groups of
GERD patients were treated with PPI for at least 1 year
which allows conclusions on the clinical impact on oral
conditions of PPI in this sample of patients.
With respect to the dental status, patients with remov-
able dentures were not excluded in all studies, which,
again, hampers comparison of the present results with
the literature. In a recent study [13], three patients with
GERD were completely edentulous; however, one par-
ticipant, a 72-year old woman in the GERD group, was
found to have a mucosal lesion, a small ulcer-like lesion
associated with redness on the dorsal tongue. Accord-
ingly, it remains unclear if ulcer was attributable to the
prosthodontic construction or to GERD. In this study,
none of the subjects had removable dentures to elimin-
ate bias if mucosal alterations were caused by the pros-
thodontic construction.
Although GERD affects all age groups [21], the inci-
dence of this disease increases considerably after 40 years
of age [19]. Similarly, in this study, the mean age of pa-
tients was 48.0 ± 16.03 years in the ERD group vs. 50.9 ±
14.5 years in the NERD patients, which is in the order
published in the literature [20]. Moreover, with respect
to age, there was no statistically significant difference be-
tween the ERD and the NERD group in this study. In ac-
cordance with the literature, among all 71 GERD
patients, a total of 41 (55.7 %) were females. Also in pre-
viously published studies, a higher incidence of GERD in
women has been reported [23]. With respect to ethni-
city, number of teeth and smoking habits, no differences
were found. Due to the fact that the smokers among the
study participants did not consume other forms of to-
bacco such as spit tobacco, cigars or pipes, the study fo-
cussed on “cigarette smoking”. Therefore, due to the fact
that the aforementioned characteristics were very similar
in both groups, the results of this study seem not to be
compromised by these general factors.
Due to the fact that all study participants had con-
firmed to attend regularely medical and dental care, it
seems unlikely that periodontal findings in this study
may be attributed to lack of accessing routine dental
care including dental prophylaxis. All 71 patients
(100 %) were prescribed periodically PPI over the
long term. However, three patients of the NERD
group were classified as non responders. Clinical effi-
cacy of PPI medication has been documented by
Wang and coworkers who collected gastric fluid dur-
ing routine endoscopy in patients on PPIs, on H2-
receptor blockers and on no acid suppression therapy
[24]. The mean pH values were 5.11, 4.12 and 2.91,
respectively. However, a recent study has PPI even
proved to be ineffective in a number of patients [2].
Data from a meta analysis have shown that a high-
dose proton pump inhibitor is no more effective than
placebo in producing symptomatic improvement or
resolution of laryngo-pharyngeal symptoms [25]. Ac-
cordingly, the three non responders found in this
study are in accordance with the literature.
Table 3 Periodontal findings. Significantly more patients
suffering from severe periodontitis in the ERD group
Parameter ERD group
(n= 29)
NERD group
(n=42)
p Difference
significant?
Plaque index 0.76 ± 0.74 0.5 ± 0.55 0.09 No
(Mean ± SD)
BOP (%) 35.5 ± 16.4 31.3 ± 18.2 0.32 No
(Mean ± SD)
CAL (mm) 7.4 ± 1.6 6.5 ± 0.5 0.35 No
Severe
periodontitis
73.1 % (22/29) 35.7 % (15/42) p < 0.001 Yes
(CAL≥ 5 mm)
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Many investigators have proposed an association between
GERD and laryngo-pharyngeal symptoms such as hoarse-
ness, globus pharyngeus, vocal fatigue, frequent sore throat,
frequent throat clearing, chronic cough [26–30]. Moreover,
oral mucosal lesions may result from GERD by direct acid
or acidic vapor contact in the oral cavity [9].
It has been demonstrated histopathologically in the rat
model that reflux affects the soft palate, which suggests
that these pathological changes may reflect the relation-
ship between laryngopharyngeal reflux and airway ob-
struction [5]. One clinical large case-controlled study
observed a significant association of GERD with ery-
thema of the palatal mucosa and uvula [7]. In another
study, histologic examination of palatal mucosa found a
greater prevalence of epithelial atrophy, deepening of
epithelial crests in connective tissue and a higher preva-
lence of fibroblasts in 31 GERD patients compared with
14 control subjects [6]. But, these changes were not vis-
ible to the naked eye, unlike the mucosal changes that
may be more readily observed in esophagitis and laryngi-
tis where the pH of the gastric reflux at these sites is
lower than in the mouth [31, 32]. Other studies have not
found any abnormal appearances of the oral mucosa or
associated oral symptoms in patients with confirmed
GERD [8, 11].
Also in this study, there was no statistical significant
difference with regard to the total number of oral muco-
sal lesions and their localization when the ERD and the
NERD group were compared. However, there is a pau-
city of information on the effect of GERD and PPI on
oral mucosal changes in the literature. Acid regurgita-
tion may exacerbate oral mucosal changes associated
with co-existing hyposalivation, which can arise from
systemic conditions, local salivary gland conditions and
intake of drugs including PPIs [9]. PPIs inhibit the H+/K
+-ATPase pump in the stomach and other tissue [33].
Altman and coworkers have demonstrated the presence
of this pump in laryngeal seromucinous glands [34]. In
addition, there is evidence that systemic medication may
enter saliva through diffusion [35]. Thus, it is possible
for the pH of the seromucinous secretions to be affected
by PPI use, and this could alter the oral mucosa, and, in
addition, the bacteria growth environment in the oro-
pharynx [33]. Especially, patients with diabetes and a
history of recent PPI use are more likely to have abnor-
mal oral flora [33]. However, due to the fact that lesions
of the oral mucosa did not differ significantly between
the ERD and the NERD group in the current study it
may be assumed that PPI medication had no adverse im-
pact on oral mucosal health in both groups.
Periodontal evaluation consisted of clinical three di-
mensional evaluation by probing due to the fact that two
dimensional radiographs are not highly reflective of the
real periodontal situation [36]. With respect to the oral
plaque index, bleeding index and clinical attachment
loss, similar levels were found in both groups (Table 3).
Differences between these two groups were not statisti-
cally significant on the 5 % level. However, significantly
more ERD patients suffered from severe periodontitis
(CAL ≥ 5 mm) as compared to NERD patients. This is,
in part, in accordance with the most recent literature.
Also Song and coworkers [12] have shown that GERD
was independently associated with an increased inci-
dence of chronic periodontitis. The most reasonable ex-
planation for GERD as a predisposing factor for chronic
periodontitis would be poor salivary function [12], which
has been demonstrated in GERD patients in several pa-
pers [7, 37, 38]. Nevertheless, hyposalivation can explain
the present findings only in part, because incidence of
severe periodontitis was different in ERD and NERD pa-
tients. Accordingly, it may be assumed in concordance
with the mucosal findings in this study that PPI medica-
tion had no adverse effect on periodontal health in ERD
and NERD patients. Other parameters such as more ag-
gressive acidic reflux must contribute to the more severe
periodontal destruction in ERD patients. Unfortunately,
to our knowledge, there is no similar study in the litera-
ture available on periodontitis in ERD and NERD pa-
tients. Therefore, further studies are available in GERD
subgroup patients.
This study has some limitations. First, patients were
recruited from an outpatient setting of a university hos-
pital. Therefore, it cannot be excluded that patients are
not representative for the whole population. Second, sal-
ivary gland function has not been evaluated. It can not
be excluded completely that ERD and NERD patients
show different degrees of hyposalivation. Third, fre-
quency and chronicity of use of tobacco were not re-
corded. Accordingly, it can not be excluded that
frequency and chronicity of use of tobacco differed sig-
nificantly between the two groups (ERD, NERD). Four,
erythema and ulceration of the oral mucosa is a very
common finding with multiple confounding etiologies. It
can not be excluded that some lesions in this group of
GERD patients are caused by other origin and not by re-
flux acid.
Conclusions
Within the limitations of this study, the authors failed to
demonstrate significant differences between ERD and
NERD patients with respect to the prevalence of acidic
lesions of the oral mucosa and their localization. There-
fore, the association of GERD and oral erythema could
not be demonstrated in the present patients. In contrast,
the results indicated that ERD patients may suffer from
more severe periodontitis as compared to NERD pa-
tients. However, the study failed to show a clinical im-
pact of long term PPI medication on the prevalence of
Deppe et al. BMC Oral Health  (2015) 15:84 Page 5 of 7
acidic oral mucosal lesions and periodontal destruction.
Further studies are necessary to elucidate the role of re-
flux in the periodontal destruction of especially ERD
individuals.
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